Form 4: Myriad Genetics CEO Paul J. Diaz Reports Share Withholdings for Tax Obligations

Paul J. Diaz, President and CEO of Myriad Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Summary

• Paul J. Diaz, the President and CEO of Myriad Genetics, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• The report indicates that shares were withheld by Myriad Genetics to satisfy tax withholding obligations related to the vesting of restricted stock units and performance-based restricted stock units.
• These transactions occurred on March 22, 2025, and March 24, 2025.
• The price per share for the withheld shares was $10.01 on March 22, 2025, and $9.98 on March 24, 2025.
• Following these transactions, Diaz directly owns 891,844 shares of Myriad Genetics common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing share withholdings for tax purposes, indicating a neutral sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard tax-related share withholdings, which are common when restricted stock units vest.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates

Keywords

Form 4, beneficial ownership, stock withholding, tax obligations, restricted stock units, Myriad Genetics, Paul J. Diaz